Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum
CALGB 80405
E5202 A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin vs 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients With Stage II Colon Cancer at High Risk for Recurrence, to Determine Prospectively the Prognostic Value of Molecular Markers
E5202
A Clinical Trial Comparing Preoperative Radiation Therapy And Capecitabine with Preoperative Radiation Therapy And Continuous Intravenous Infusion (CVI) of 5-Fluorouracil (5-FU) in The Treatment of Patients With Operable Carcinoma of The Rectum
NSABP R-04
|
